Medley Pharma`s Generic Lacosamide Receives Approval in the U.S.
Amneal Pharm Generic Lacosamide Receives Approval in the U.S.
PISCATAWAY, N.J., Feb. 26, 2024 /PRNewswire/ -- Aucta Pharmaceuticals, Inc., a private specialty pharmaceutical company focused on niche generic and branded specialty products, today announced the commercial launch of MOTPOLY XR (lacosamide) extended-release capsules C-V (100, 150 and 200 mg). MOTPOLY XR is approved for the treatment of partial-onset seizures in adults and in pediatric patients weighing at least 50 kg.
Hainan Poly`s Generic Lacosamide Receives Approval in the U.S.
Aurobindo Pharma`s Generic Lacosamide Receives Approval in the U.S.
Extrovis` Lacosamide Adroiq (lacosamide) Receives Approval in Europe
Aurobindo' Generic Lacosamide Receives Approval in the U.S.
Actavis' Generic Lacosamide Receives Approval in the U.S.